Disease | b-cell lymphomas |
Comorbidity | C0019158|hepatitis |
Sentences | 9 |
PubMedID- 24270404 | Outcome prediction of diffuse large b-cell lymphomas associated with hepatitis c virus infection: a study on behalf of the fondazione italiana linfomi. |
PubMedID- 22736295 | Clinical outcome in diffuse large b-cell lymphoma with hepatitis c virus infection in the rituximab era: a single center experience. |
PubMedID- 20554488 | Hcv-positive status and hepatitis flares in patients with b-cell non-hodgkin's lymphoma treated with rituximab-containing regimens. |
PubMedID- 25381127 | The notch pathway is recurrently mutated in diffuse large b-cell lymphoma associated with hepatitis c virus infection. |
PubMedID- 22395482 | b-cell lymphoma in hepatitis c virus (hcv)-seropositive patients frequently presents with extranodal disease in the bone marrow, major salivary glands, or spleen [1, 2]. |
PubMedID- 24060287 | Bendamustine and rituximab for indolent b-cell non-hodgkin lymphoma in patients with compensated hepatitis c cirrhosis: a case series. |
PubMedID- 25339404 | Fatal outcome of autochthonous hepatitis e in a patient with b cell lymphoma in southeastern france. |
PubMedID- 25848698 | We performed a retrospective study to analyse the characteristics and clinical outcomes of diffuse large b-cell lymphoma (dlbcl) patients with hepatitis b virus (hbv) infection and compare with those without hbv infection. |
PubMedID- 23465418 | Early-stage splenic diffuse large b-cell lymphoma is highly associated with hepatitis c virus infection. |
Page: 1